As reported, through caspase-9–3-7-PARP signaling, SOX11 silencing promotes proliferation and inhibits the apoptosis of MCL cells and desensitizes MCL cells to bortezomib [101]. The gene discussed is CASP9; the disease is mantle cell lymphoma.